SM-Youtube

Year	Number of Results
1980	3
1981	6
1982	11
1983	51
1984	21
1985	22
1986	20
1987	10
1988	14
1989	15
1990	28
1991	24
1992	22
1993	21
1994	24
1995	19
1996	18
1997	22
1998	48
1999	58
2000	79
2001	123
2002	132
2003	123
2004	157
2005	167
2006	157
2007	162
2008	185
2009	162
2010	164
2011	166
2012	158
2013	173
2014	151
2015	149
2016	154
2017	116
2018	103
2019	106
2020	99
2021	96
2022	100
2023	104
2024	55

Year

Number of Results

1980

1981

1982

1983

1984

1985

1986

1987

1988

1989

1990

1991

1992

1993

1994

1995

1996

1997

1998

1999

2000

2001

123

2002

132

2003

123

2004

157

2005

167

2006

157

2007

162

2008

185

2009

162

2010

164

2011

166

2012

158

2013

173

2014

151

2015

149

2016

154

2017

116

2018

103

2019

106

2020

2021

2022

100

2023

104

2024

Page 1

Bupropion-myth-busting!

Naguy A, Badr BHM. Naguy A, et al. CNS Spectr. 2022 Oct;27(5):545-546. doi: 10.1017/S1092852921000365. Epub 2021 Apr 12. CNS Spectr. 2022. PMID: 33843549 No abstract available.

Pharmacokinetic and pharmacodynamic of bupropion: integrative overview of relevant clinical and forensic aspects.

Costa R, Oliveira NG, Dinis-Oliveira RJ. Costa R, et al. Drug Metab Rev. 2019 Aug;51(3):293-313. doi: 10.1080/03602532.2019.1620763. Epub 2019 Jun 14. Drug Metab Rev. 2019. PMID: 31124380 Review.

Naltrexone-bupropion (Mysimba) in management of obesity: A systematic review and meta-analysis of unpublished clinical study reports.

Onakpoya IJ, Lee JJ, Mahtani KR, Aronson JK, Heneghan CJ. Onakpoya IJ, et al. Br J Clin Pharmacol. 2020 Apr;86(4):646-667. doi: 10.1111/bcp.14210. Epub 2020 Feb 4. Br J Clin Pharmacol. 2020. PMID: 31918448 Free PMC article. Review.

Dextromethorphan/Bupropion: A Novel Oral NMDA (N-methyl-d-aspartate) Receptor Antagonist with Multimodal Activity.

Stahl SM. Stahl SM. CNS Spectr. 2019 Oct;24(5):461-466. doi: 10.1017/S1092852919001470. CNS Spectr. 2019. PMID: 31566163 Review.

Naltrexone-Bupropion and Behavior Therapy, Alone and Combined, for Binge-Eating Disorder: Randomized Double-Blind Placebo-Controlled Trial.

Grilo CM, Lydecker JA, Fineberg SK, Moreno JO, Ivezaj V, Gueorguieva R. Grilo CM, et al. Am J Psychiatry. 2022 Dec 1;179(12):927-937. doi: 10.1176/appi.ajp.20220267. Epub 2022 Oct 26. Am J Psychiatry. 2022. PMID: 36285406 Free PMC article. Clinical Trial.

Auvelity (dextromethorphan/bupropion).

Abuzoor A, El-Alfy AT, Busse K. Abuzoor A, et al. WMJ. 2023;122:P4. WMJ. 2023. PMID: 36724488 No abstract available.

Dextromethorphan/Bupropion: First Approval.

Keam SJ. Keam SJ. CNS Drugs. 2022 Nov;36(11):1229-1238. doi: 10.1007/s40263-022-00968-4. CNS Drugs. 2022. PMID: 36301443 Review.

Bupropion-Associated Seizures.

Naguy A, Pridmore S, Alamiri B. Naguy A, et al. Am J Ther. 2024 May-Jun 01;31(3):e331-e332. doi: 10.1097/MJT.0000000000001669. Epub 2023 Oct 16. Am J Ther. 2024. PMID: 38091263 No abstract available.

Dextromethorphan-Bupropion for the Treatment of Depression: A Systematic Review of Efficacy and Safety in Clinical Trials.

Akbar D, Rhee TG, Ceban F, Ho R, Teopiz KM, Cao B, Subramaniapillai M, Kwan ATH, Rosenblat JD, McIntyre RS. Akbar D, et al. CNS Drugs. 2023 Oct;37(10):867-881. doi: 10.1007/s40263-023-01032-5. Epub 2023 Oct 4. CNS Drugs. 2023. PMID: 37792265

Naltrexone + Bupropion Combination for the Treatment of Binge-eating Disorder with Obesity: A Randomized, Controlled Pilot Study.

Grilo CM, Lydecker JA, Morgan PT, Gueorguieva R. Grilo CM, et al. Clin Ther. 2021 Jan;43(1):112-122.e1. doi: 10.1016/j.clinthera.2020.10.010. Epub 2020 Nov 18. Clin Ther. 2021. PMID: 33218742 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

3,417 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Search Results

3,417 results

Results by year